| 0 |
CHRONIC INFLAMMATORY RESPONSE SYNDROME |
1 |
0.0244 |
| 1 |
DELAYED SLEEP PHASE |
1 |
0.0122 |
| 2 |
BACTERIAL VULVOVAGINITIS |
1 |
0.0035 |
| 3 |
NASAL TURBINATE HYPERTROPHY |
1 |
0.0027 |
| 4 |
EHLERS-DANLOS SYNDROME |
1 |
0.0022 |
| 5 |
VITRECTOMY |
1 |
0.0017 |
| 6 |
ISCHAEMIC HEPATITIS |
2 |
0.0015 |
| 7 |
PNEUMONIA MYCOPLASMAL |
1 |
0.0013 |
| 8 |
CIRCADIAN RHYTHM SLEEP DISORDER |
1 |
0.0012 |
| 9 |
INFUSION SITE MASS |
1 |
0.0009 |
| 10 |
RETROPERITONEAL HAEMORRHAGE |
2 |
0.0008 |
| 11 |
SUBSTANCE USE |
1 |
0.0006 |
| 12 |
BACTERIAL VAGINOSIS |
1 |
0.0006 |
| 13 |
MEDICAL PROCEDURE |
1 |
0.0006 |
| 14 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 15 |
NASAL OBSTRUCTION |
1 |
0.0005 |
| 16 |
NARCOLEPSY |
1 |
0.0005 |
| 17 |
INFUSION SITE BRUISING |
1 |
0.0005 |
| 18 |
INFECTIOUS MONONUCLEOSIS |
1 |
0.0004 |
| 19 |
HYPOVOLAEMIC SHOCK |
2 |
0.0004 |
| 20 |
ACUTE PSYCHOSIS |
1 |
0.0004 |
| 21 |
INTESTINAL ISCHAEMIA |
2 |
0.0004 |
| 22 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 23 |
INFUSION SITE HAEMORRHAGE |
1 |
0.0003 |
| 24 |
TACHYPHRENIA |
1 |
0.0003 |
| 25 |
RESPIRATORY ACIDOSIS |
1 |
0.0003 |
| 26 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 27 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 28 |
ARTHRITIS INFECTIVE |
1 |
0.0002 |
| 29 |
ROSACEA |
1 |
0.0002 |
| 30 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0002 |
| 31 |
PHLEBITIS |
1 |
0.0002 |
| 32 |
SINUS HEADACHE |
1 |
0.0002 |
| 33 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 34 |
EPSTEIN-BARR VIRUS INFECTION |
1 |
0.0002 |
| 35 |
TROPONIN INCREASED |
1 |
0.0001 |
| 36 |
FOOD ALLERGY |
1 |
0.0001 |
| 37 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 38 |
DRUG SCREEN POSITIVE |
1 |
0.0001 |
| 39 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 40 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 41 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 42 |
EXOSTOSIS |
1 |
0.0001 |
| 43 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 44 |
DENTAL CARIES |
1 |
0.0001 |
| 45 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 46 |
BURSITIS |
1 |
0.0001 |
| 47 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 48 |
TOOTH INFECTION |
1 |
0.0001 |
| 49 |
ADVERSE REACTION |
1 |
0.0001 |
| 50 |
ACUTE HEPATIC FAILURE |
1 |
0.0001 |
| 51 |
INSURANCE ISSUE |
1 |
0.0001 |
| 52 |
CYTOMEGALOVIRUS INFECTION |
1 |
0.0001 |
| 53 |
CANDIDA INFECTION |
1 |
0.0001 |
| 54 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 55 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 56 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 57 |
FOOT FRACTURE |
1 |
0.0001 |
| 58 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 59 |
SEROTONIN SYNDROME |
1 |
0.0001 |
| 60 |
JOINT INJURY |
1 |
0.0000 |
| 61 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 62 |
DRUG RESISTANCE |
1 |
0.0000 |
| 63 |
EAR INFECTION |
1 |
0.0000 |
| 64 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 65 |
VIRAL INFECTION |
1 |
0.0000 |
| 66 |
FUNGAL INFECTION |
1 |
0.0000 |
| 67 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 68 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 69 |
COMPLETED SUICIDE |
2 |
0.0000 |
| 70 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 71 |
POLLAKIURIA |
1 |
0.0000 |
| 72 |
SEPTIC SHOCK |
1 |
0.0000 |
| 73 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 74 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 75 |
ECZEMA |
1 |
0.0000 |
| 76 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 77 |
ARTHROPATHY |
1 |
0.0000 |
| 78 |
CATARACT |
1 |
0.0000 |
| 79 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 80 |
BRONCHITIS |
1 |
0.0000 |
| 81 |
DRUG INTERACTION |
2 |
0.0000 |
| 82 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 83 |
COVID-19 |
2 |
0.0000 |
| 84 |
ADVERSE EVENT |
1 |
0.0000 |
| 85 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 86 |
CONTUSION |
1 |
0.0000 |
| 87 |
SOMNOLENCE |
2 |
0.0000 |
| 88 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 89 |
INFLUENZA |
1 |
0.0000 |
| 90 |
ASTHMA |
1 |
0.0000 |
| 91 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 92 |
INFECTION |
1 |
0.0000 |
| 93 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 94 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 95 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 96 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 97 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 98 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 99 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 100 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 101 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 102 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 103 |
DEPRESSION |
1 |
0.0000 |
| 104 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 105 |
FEELING ABNORMAL |
1 |
0.0000 |
| 106 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 107 |
OFF LABEL USE |
3 |
0.0000 |
| 108 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 109 |
DIARRHOEA |
2 |
0.0000 |
| 110 |
PNEUMONIA |
1 |
0.0000 |
| 111 |
ARTHRALGIA |
1 |
0.0000 |
| 112 |
DIZZINESS |
1 |
0.0000 |
| 113 |
PAIN |
1 |
0.0000 |
| 114 |
HEADACHE |
1 |
0.0000 |
| 115 |
DRUG INEFFECTIVE |
2 |
0.0000 |
| 116 |
FATIGUE |
1 |
0.0000 |